Lopinavir/Ritonavir Pharmacokinetics in a Substitution of High-Dose Soft-Gelatin Capsule to Tablet Formulation

MLA

Marianne Harris, et al. “Lopinavir/Ritonavir Pharmacokinetics in a Substitution of High-Dose Soft-Gelatin Capsule to Tablet Formulation.” The Journal of Clinical Pharmacology, vol. 49, Feb. 2009, pp. 155–61. EBSCOhost, https://doi.org/10.1177/0091270008329550.

APA

Marianne Harris, Viviane D. Lima, Silvia Guillemi, P. Richard Harrigan, Julio S. G. Montaner, & MHSc Mark W. Hull Md. (2009). Lopinavir/Ritonavir Pharmacokinetics in a Substitution of High-Dose Soft-Gelatin Capsule to Tablet Formulation. The Journal of Clinical Pharmacology, 49, 155–161. https://doi.org/10.1177/0091270008329550

Chicago

Marianne Harris, Viviane D. Lima, Silvia Guillemi, P. Richard Harrigan, Julio S. G. Montaner, and MHSc Mark W. Hull Md. 2009. “Lopinavir/Ritonavir Pharmacokinetics in a Substitution of High-Dose Soft-Gelatin Capsule to Tablet Formulation.” The Journal of Clinical Pharmacology 49 (February): 155–61. doi:10.1177/0091270008329550.